NCT05396638View on ClinicalTrials.gov

Characterization of Endocannabinoid and Endogenous Opioid Levels in Adolescents With Cannabis Use Disorder

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 13, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Cannabis Use
Interventions
BEHAVIORAL

Contingency Management

Participants will be paid for abstinence at each study visit.

Trial Locations (1)

80045

RECRUITING

University of Colorado Anschutz Medical Campus, Aurora

All Listed Sponsors
collaborator

Colorado Clinical & Translational Sciences Institute

OTHER

lead

University of Colorado, Denver

OTHER

NCT05396638 - Characterization of Endocannabinoid and Endogenous Opioid Levels in Adolescents With Cannabis Use Disorder | Biotech Hunter | Biotech Hunter